About this trial
Increased numbers of white blood cells called eosinophils can cause disease. To investigate this disease, researchers need blood, urine, sputum, stool, cerebrospinal fluid, skin and/or bone marrow samples to compare to samples from patients with this problem. Some of the samples will be used for genetic testing or future research.
This study will last for about 10 years and will include a maximum of 50 paid volunteers ages 18 to 65.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
ability to sign informed consent
healthy male or female
18-85 years of age
Disqualifiers
pregnancy
weight <110 pounds
history of heart, lung, kidney disease, chronic anemia or bleeding disorders
ability to sign informed consent
Trial population
Healthy volunteers.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
- To provide an IRB-approved mechanism for the collection of peripheral blood, urine, sputum, stool, cerebrospinal fluid, skin biopsy and bone marrow samples from paid, volunteer donors for use in in vitro studies.
\- To provide adequate and complete informed consent to the donors of research blood samples, and to assure that the education, counseling and protection of the study subjects from research risks is performed in accordance with IRB, OHRP, and other applicable Federal regulatory standards.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.